Certified by Founder Lodge
Reverb Therapeutics

START UP
1 Disclosed Funding Rounds $21,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We develop bispecific antibodies that exploit the potential of the natural immune system. Our Amplify•R platform amplifies and redirects endogenous cytokine signaling instead of recombinant
Date | Round | Raised | Participating Investors |
---|---|---|---|
February, 21 ,2025 | Seed | $21,000,000 |